![Jordi Gilberte](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jordi Gilberte
Founder at
GENINCODE PLC
Net worth: 180 195 $ as of 30/06/2026
Profile
Mr. Jordi P.
Gilberte is a Chief Operations Officer & Executive Director at GENinCode Plc.
He is on the Board of Directors at GENinCode Plc, GEN inCode U.S., Inc. and GENinCode SLU.
Mr. Gilberte was previously employed as a Chief Executive Officer & Director by Ferrer inCode SL and a Chief Financial Officer & Director by Gendiag Exe SL.
He also served on the board at Gendiag SL.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
GENINCODE PLC 1.94% | 31/12/2024 | 1,46,02,500 ( 1.94% ) | 180 195 $ | 30/06/2026 |
Jordi Gilberte active positions
| Companies | Position | Start |
|---|---|---|
| GENINCODE PLC | Founder | 06/09/2018 |
GENinCode SLU | Director/Board Member | - |
GEN inCode U.S., Inc. | Director/Board Member | - |
Former positions of Jordi Gilberte
| Companies | Position | End |
|---|---|---|
Ferrer inCode SL | Chief Executive Officer | 01/09/2018 |
Gendiag Exe SL
 Gendiag Exe SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Director of Finance/CFO | 01/09/2018 |
Gendiag SL
 Gendiag SL BiotechnologyHealth Technology Researches and develops bio technology products | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Gendiag SL
Gendiag SL BiotechnologyHealth Technology Researches and develops bio technology products | Health Technology |
GENinCode Plc
 GENinCode Plc Packaged SoftwareTechnology Services Develops risk assessment and prediction solutions for cardiovascular disease, thrombosis and familial hypercholesterolemia | Technology Services |
Ferrer inCode SL | |
Gendiag Exe SL
Gendiag Exe SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
GENinCode SLU | |
GEN inCode U.S., Inc. |
- Stock Market
- Insiders
- Jordi Gilberte
